Medication Recommendations for Depression and Amotivation

Assessment and Treatment Modification

The American College of Physicians recommends treatment modification when patients fail to respond adequately to antidepressants within 6-8 weeks, such as switching to a different second-generation antidepressant or augmenting the current regimen with another agent 1, 2, 3
Patients on maximum-dose bupropion who present with persistent depression and amotivation indicate treatment failure that requires intervention, as recommended by the American College of Physicians 1, 2, 3

The American College of Physicians suggests adding an SSRI or SNRI to the current regimen rather than switching entirely, as combination therapy may be beneficial in treatment-resistant depression 1, 2
Specific augmentation choices include Sertraline 50-200 mg daily or Escitalopram 10-20 mg daily, which are weight-neutral with long-term use and have favorable tolerability profiles, as recommended by the American Gastroenterological Association and the American College of Physicians 3, 4

Assess response within 1-2 weeks of any medication change, then regularly thereafter, and monitor for suicidal ideation, agitation, irritability, unusual behavioral changes, as recommended by the American College of Physicians 1, 2, 3
Evaluate depressive symptoms and functional improvement, and screen for treatment-emergent adverse effects, as recommended by the American College of Physicians 1, 3

Bupropion lowers seizure threshold, with a risk of 0.1% at doses ≤450 mg/day, and patients should be counseled to minimize alcohol use, as recommended by the National Comprehensive Cancer Network 5
The American College of Physicians notes that bupropion has significantly lower rates of sexual dysfunction compared to fluoxetine or sertraline, which may favor keeping bupropion in the regimen 1, 2, 3
Once adequate response is achieved, continue antidepressant therapy for 4-9 months minimum, as recommended by the American College of Physicians 3

The American Academy of Family Physicians recommends switching to bupropion SR 150mg twice daily for improved adherence and more stable drug levels in patients taking immediate-release bupropion 100mg TID 6
Augmentation with an SSRI is the stronger evidence-based approach for treatment-resistant depression, as it addresses depression through complementary mechanisms 6

The maximum FDA-approved dose for bupropion SR is 400mg daily, allowing for dose escalation to 200mg twice daily if augmentation is not preferred 6